QuidelOrtho
QDEL

QuidelOrtho (QDEL) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
CitigroupMaintainedNeutral$18.00 from $13.00Jul 8, 2026
JP MorganMaintainedUnderweight$12.00 from $11.00Jul 1, 2026
JefferiesDowngradedBuy → Hold$12.50 from $35.00May 7, 2026
CitigroupMaintainedNeutral$13.00 from $30.00May 6, 2026
UBSMaintainedNeutral$17.00 from $30.00Apr 10, 2026
CitigroupMaintainedNeutral$30.00 from $23.00Feb 12, 2026
UBSMaintainedNeutral$35.00 from $31.00Jan 21, 2026
JP MorganMaintainedUnderweight$22.00 from $26.00Nov 7, 2025
UBSMaintainedNeutral$31.00 from $26.00Nov 6, 2025
CitigroupDowngradedBuy → Neutral$33.00 from $40.00Oct 7, 2025
UBSMaintainedNeutral$26.00 from $29.00Aug 7, 2025
CitigroupMaintainedBuy$40.00 from $50.00Aug 6, 2025
JefferiesUpgradedHold → Buy$44.00May 8, 2025
UBSMaintainedNeutral$29.00 from $45.00May 8, 2025
JP MorganMaintainedUnderweight$25.00 from $38.00Apr 21, 2025
UBSMaintainedNeutral$45.00 from $43.00Feb 13, 2025
RBC CapitalMaintainedOutperform$61.00 from $64.00Feb 13, 2025
CitigroupUpgradedNeutral → Buy$50.00 from $44.00Dec 11, 2024
JefferiesInitiated CoverageHold$43.00Dec 10, 2024
UBSUpgradedSell → Neutral$50.00 from $42.00Sep 19, 2024

Frequently asked questions

  • What is the latest analyst rating on QDEL?

    On Jul 8, 2026, Citigroup maintained QuidelOrtho at Neutral with a price target of $18.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.